Drug Approval | August 13, 2025
Indoco Remedies receives final USFDA approval for rivaroxaban tablets
Rivaroxaban is used to treat venous thromboembolism
Rivaroxaban is used to treat venous thromboembolism
Haloperidol Decanoate Injection indicated for the treatment of patients with schizophrenia who require prolonged parenteral antipsychotic therapy
The product will be launched in Q1FY26
Rivaroxaban Tablets USP, 2.5 mg, is bioequivalent to Xarelto® Tablets, 2.5 mg of Janssen Pharmaceuticals
No safety signals related to the vaccine candidate were identified
Paliperidone extended-release tablets are an atypical antipsychotic agent indicated for treatment of schizophrenia
The company has received five final approvals
Subscribe To Our Newsletter & Stay Updated
